Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of Leukocyte Biology|April 1, 1995
The role of the innate immune response in Th1 cell development following Leishmania major infectionT Scharton-Kersten, P ScottExpert Opinion on Investigational Drugs|July 5, 2005
Advances in vaccine delivery: transcutaneous immunisationG M Glenn, T Scharton-Kersten, C R AlvingExperimental Parasitology|November 1, 1996
Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strainT Scharton-Kersten, P Caspar, A Sher, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivoG S Yap, T Scharton-Kersten, H Charest, et al.The Journal of Experimental Medicine|November 14, 1997
Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 inductionT Scharton-Kersten, C Contursi, A Masumi, et al.The Journal of Experimental Medicine|July 1, 1996
A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infectionE Y Denkers, T Scharton-Kersten, S Barbieri, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 24, 1998
Infection of mice lacking the common cytokine receptor gamma-chain (gamma(c)) reveals an unexpected role for CD4+ T lymphocytes in early IFN-gamma-dependent resistance to Toxoplasma gondiiT Scharton-Kersten, H Nakajima, G Yap, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995
IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasisT Scharton-Kersten, L C Afonso, M Wysocka, et al.Infection and Immunity|February 20, 1999
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvantsG M Glenn, T Scharton-Kersten, R Vassell, et al.Infection and Immunity|August 19, 2000
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvantsT Scharton-Kersten, J m Yu, R Vassell, et al.Pageof 3